Kacey Morrissey: After Biden Win, Don’t Expect Cannabis Legalization

Even though a a Joe Biden presidency offers a rosier outlook for the US cannabis industry, a leading data expert doesn’t anticipate federal legalization in the immediate future.

“Even if they do a federal decriminalization, we don’t see there being federal legalization or an implementation of anything that would then create a sort of inter-state commerce,” Kacey Morrissey, New Frontier Data’s senior director, industry analytics, told the Investing News Network.

The expert said the growth of cannabis in the US will still be dependent on the state markets.

The industry was keen on this election not just for the potential for stronger reforms at the federal level, but because five states were looking to legalize the plant in some form.

Arizona, Mississippi, Montana, New Jersey and South Dakota asked voters to determine the future of their state cannabis programs. All five state measures were approved, which Morrissey said is another strong win for cannabis policy and an indication of the drug’s popularity regardless of political alignment.

“As far as an election year, 2020 is the most consequential election that we’ve seen for cannabis,” said Morrissey, who was speaking last Wednesday (November 5), before the election was officially called for Biden. The results of the state votes had been announced at that time.

The expert said that thanks to the positive state ballot results for cannabis, over 70 percent of the US population now lives in a territory with a legal cannabis framework. “Over a third of all Americans live in a legal adult market where they can now purchase recreational cannabis,” she said.

In the lead-up to election night, New Frontier Data published a report offering facts and figures about the significance of this election for the cannabis industry at large. It projected that if all state measures won their respective votes, the US market could see a combined revenue boost of US$3.3 billion by 2025.

“Given the latest state initiatives in play during this year’s elections, New Frontier Data expects their impact to reach far beyond 2021, further unfolding what we expect will be continued significant social, economic, and legislative reform expansion during this unprecedentedly disruptive COVID-19 pandemic,” Giadha DeCarcer, founder and CEO of New Frontier Data, said in the report.

Watch the video above to hear Morrissey’s full thoughts on the outlook for cannabis given the new US president. You can also click here for more cannabis videos on YouTube.

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

Editorial Disclosure: The Investing News Network does not guarantee the accuracy or thoroughness of the information reported in the interviews it conducts. The opinions expressed in these interviews do not reflect the opinions of the Investing News Network and do not constitute investment advice. All readers are encouraged to perform their own due diligence.

The Israeli cannabis market is picking up with a new supply deal from a Canadian producer.

Also this week, new data showed sales of Canadian cannabis edible products may be stalling.

Keep reading... Show less

The Israeli cannabis market is picking up as a Canadian producer announced a new supply deal in the country.

Also this week it was shown the sales of Canadian cannabis edible products may be stalling, according to new data.

Keep reading... Show less

The Portnoy Law Firm advises investors that class action lawsuits have been filed on behalf of investors in the following publicly traded companies. Shareholders interested in taking an active role in these cases have until the deadlines indicated below to petition the court. There is no cost or obligation to you. See below for more information on these cases.

Credit Acceptance Corporation investors (NASDAQ: CACC); December 1, 2020 deadline, click here to join .

Keep reading... Show less
  • On November 19 , the Mexican Senate passed comprehensive adult-use cannabis legalization, moving Mexico towards becoming one of the few countries to legalize cannabis nationally
  • On March 31, 2020 , the Company entered into an agreement with Tecnologico de Monterrey , the leading university in Mexico , to educate physicians across Latin America , in advance of the impending regulations in Mexico
  • To date, close to 550 LatAm physicians have obtained their diploma accrediting completion of Khiron’s medical education program
  • The Company plans to deploy its ZereniaTM medical cannabis clinics and telehealth strategy in Mexico , building on the success of its vertical integration strategy in Colombia
  • Expanding the Zerenia clinic strategy will build on the Company’s Colombia knowledge and proven distribution capabilities, with rapid telehealth service adoption and over 5,600 medical cannabis scripts filled to date
  • Mexico represents one of the largest potential markets for medical cannabis in the world and is anticipated to reach $1.2bn USD by 2028 (Prohibition Partners).
  • Company to release Q3 2020 financials and host webcast on Tuesday, December 1st

Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN ), (OTCQX: KHRNF), ( Frankfurt : A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe welcomes the passing of adult-use cannabis legislation by the Mexican Senate, which moves the country closer to a legalized cannabis market, and towards provision for medical cannabis products.  Khiron has had a presence in Mexico since 2018 and has been working with doctors and medical institutions to develop a deep understanding of the market.

Keep reading... Show less

Recap of special management call includes upcoming corporate milestones and details of proposed combination with established beverage manufacturer

Emerging leader in infused cannabis beverages, BevCanna Enterprises Inc. (CSE:BEV, OTCQB:BVNNF, FSE:7BC) (“BevCanna” or the “Company”) is pleased to provide a recorded recap of the special management call held on Tuesday November 24, 2020. The call discussed upcoming corporate milestones and reviewed recent developments at the developer and manufacturer of cannabinoid‐infused beverages and consumer products for in‐house brands and white label clients.

Keep reading... Show less